🔎 Trials Near Me

Akèy › Kansè renn (Kasinom selil renn) › Michigan › Ann Arbor

Etid klinik pou Kansè renn (Kasinom selil renn) nan Ann Arbor, MI

12 etid pou Kansè renn (Kasinom selil renn) ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • ak 4 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

Ap rekriteFaz 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Ap rekriteFaz 1
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT07195916

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Ap rekriteFaz 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT06661720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

Ap rekriteFaz 1
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT06966024

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

Ap rekriteFaz 1/2
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT06866262

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Ap rekriteFaz 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi lwen
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT07383441

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

Ap rekriteFaz 1
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

Ap rekriteFaz 2
  • University of Michigan, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT06053658

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Ap rekriteFaz 1
  • University of Michigan Hospitals, Ann Arbor
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Ap rekriteFaz 3
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2025 · NCT04510597

Etid Kansè renn (Kasinom selil renn) nan lòt vil

Lòt etid nan Ann Arbor

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.